Global Subcutaneous Biologics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 47720
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Medical Devices
Buy @ $3500

The Subcutaneous Biologics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Subcutaneous Biologics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Subcutaneous Biologics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Subcutaneous Biologics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Syringe

Wearable injector

Automatic injector

Implants

Market segment by Application, can be divided into

Hospital pharmacies

Retail pharmacies

Drug stores

Online pharmacies

Market segment by players, this report covers

Abbott Laboratories

Pfizer Inc.

Genentech Inc.

Novartis AG

Biogen Idec

AbbVie Inc.

F. Hoffmann-La Roche AG

Bristol-Myers Squibb

Eisai Inc.

Takeda Pharmaceuticals Ltd.

Alnylam Pharmaceuticals

Bayer AG

GlaxoSmithKline

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Subcutaneous Biologics

1.2 Classification of Subcutaneous Biologics by Delivery System

1.2.1 Overview: Global Subcutaneous Biologics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Subcutaneous Biologics Revenue Market Share by Type in 2020

1.2.3 Syringe

1.2.4 Wearable injector

1.2.5 Automatic injector

1.2.6 Implants

1.3 Global Subcutaneous Biologics Market by Distribution Channel

1.3.1 Overview: Global Subcutaneous Biologics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital pharmacies

1.3.3 Retail pharmacies

1.3.4 Drug stores

1.3.5 Online pharmacies

1.4 Global Subcutaneous Biologics Market Size & Forecast

1.5 Global Subcutaneous Biologics Market Size and Forecast by Region

1.5.1 Global Subcutaneous Biologics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Subcutaneous Biologics Market Size by Region, (2016-2021)

1.5.3 North America Subcutaneous Biologics Market Size and Prospect (2016-2026)

1.5.4 Europe Subcutaneous Biologics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Subcutaneous Biologics Market Size and Prospect (2016-2026)

1.5.6 South America Subcutaneous Biologics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Subcutaneous Biologics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Subcutaneous Biologics Market Drivers

1.6.2 Subcutaneous Biologics Market Restraints

1.6.3 Subcutaneous Biologics Trends Analysis

2 Company Profiles

2.1 Abbott Laboratories

2.1.1 Abbott Laboratories Details

2.1.2 Abbott Laboratories Major Business

2.1.3 Abbott Laboratories Subcutaneous Biologics Product and Solutions

2.1.4 Abbott Laboratories Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Abbott Laboratories Recent Developments and Future Plans

2.2 Pfizer Inc.

2.2.1 Pfizer Inc. Details

2.2.2 Pfizer Inc. Major Business

2.2.3 Pfizer Inc. Subcutaneous Biologics Product and Solutions

2.2.4 Pfizer Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Pfizer Inc. Recent Developments and Future Plans

2.3 Genentech Inc.

2.3.1 Genentech Inc. Details

2.3.2 Genentech Inc. Major Business

2.3.3 Genentech Inc. Subcutaneous Biologics Product and Solutions

2.3.4 Genentech Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Genentech Inc. Recent Developments and Future Plans

2.4 Novartis AG

2.4.1 Novartis AG Details

2.4.2 Novartis AG Major Business

2.4.3 Novartis AG Subcutaneous Biologics Product and Solutions

2.4.4 Novartis AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Novartis AG Recent Developments and Future Plans

2.5 Biogen Idec

2.5.1 Biogen Idec Details

2.5.2 Biogen Idec Major Business

2.5.3 Biogen Idec Subcutaneous Biologics Product and Solutions

2.5.4 Biogen Idec Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Biogen Idec Recent Developments and Future Plans

2.6 AbbVie Inc.

2.6.1 AbbVie Inc. Details

2.6.2 AbbVie Inc. Major Business

2.6.3 AbbVie Inc. Subcutaneous Biologics Product and Solutions

2.6.4 AbbVie Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 AbbVie Inc. Recent Developments and Future Plans

2.7 F. Hoffmann-La Roche AG

2.7.1 F. Hoffmann-La Roche AG Details

2.7.2 F. Hoffmann-La Roche AG Major Business

2.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Product and Solutions

2.7.4 F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 F. Hoffmann-La Roche AG Recent Developments and Future Plans

2.8 Bristol-Myers Squibb

2.8.1 Bristol-Myers Squibb Details

2.8.2 Bristol-Myers Squibb Major Business

2.8.3 Bristol-Myers Squibb Subcutaneous Biologics Product and Solutions

2.8.4 Bristol-Myers Squibb Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Bristol-Myers Squibb Recent Developments and Future Plans

2.9 Eisai Inc.

2.9.1 Eisai Inc. Details

2.9.2 Eisai Inc. Major Business

2.9.3 Eisai Inc. Subcutaneous Biologics Product and Solutions

2.9.4 Eisai Inc. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Eisai Inc. Recent Developments and Future Plans

2.10 Takeda Pharmaceuticals Ltd.

2.10.1 Takeda Pharmaceuticals Ltd. Details

2.10.2 Takeda Pharmaceuticals Ltd. Major Business

2.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product and Solutions

2.10.4 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Takeda Pharmaceuticals Ltd. Recent Developments and Future Plans

2.11 Alnylam Pharmaceuticals

2.11.1 Alnylam Pharmaceuticals Details

2.11.2 Alnylam Pharmaceuticals Major Business

2.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Product and Solutions

2.11.4 Alnylam Pharmaceuticals Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Alnylam Pharmaceuticals Recent Developments and Future Plans

2.12 Bayer AG

2.12.1 Bayer AG Details

2.12.2 Bayer AG Major Business

2.12.3 Bayer AG Subcutaneous Biologics Product and Solutions

2.12.4 Bayer AG Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Bayer AG Recent Developments and Future Plans

2.13 GlaxoSmithKline

2.13.1 GlaxoSmithKline Details

2.13.2 GlaxoSmithKline Major Business

2.13.3 GlaxoSmithKline Subcutaneous Biologics Product and Solutions

2.13.4 GlaxoSmithKline Subcutaneous Biologics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 GlaxoSmithKline Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Subcutaneous Biologics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Subcutaneous Biologics Players Market Share

3.2.2 Top 10 Subcutaneous Biologics Players Market Share

3.2.3 Market Competition Trend

3.3 Subcutaneous Biologics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Subcutaneous Biologics Revenue and Market Share by Type (2016-2021)

4.2 Global Subcutaneous Biologics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Subcutaneous Biologics Revenue Market Share by Application (2016-2021)

5.2 Subcutaneous Biologics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Subcutaneous Biologics Revenue by Type (2016-2026)

6.2 North America Subcutaneous Biologics Revenue by Application (2016-2026)

6.3 North America Subcutaneous Biologics Market Size by Country

6.3.1 North America Subcutaneous Biologics Revenue by Country (2016-2026)

6.3.2 United States Subcutaneous Biologics Market Size and Forecast (2016-2026)

6.3.3 Canada Subcutaneous Biologics Market Size and Forecast (2016-2026)

6.3.4 Mexico Subcutaneous Biologics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Subcutaneous Biologics Revenue by Type (2016-2026)

7.2 Europe Subcutaneous Biologics Revenue by Application (2016-2026)

7.3 Europe Subcutaneous Biologics Market Size by Country

7.3.1 Europe Subcutaneous Biologics Revenue by Country (2016-2026)

7.3.2 Germany Subcutaneous Biologics Market Size and Forecast (2016-2026)

7.3.3 France Subcutaneous Biologics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Subcutaneous Biologics Market Size and Forecast (2016-2026)

7.3.5 Russia Subcutaneous Biologics Market Size and Forecast (2016-2026)

7.3.6 Italy Subcutaneous Biologics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Subcutaneous Biologics Revenue by Type (2016-2026)

8.2 Asia-Pacific Subcutaneous Biologics Revenue by Application (2016-2026)

8.3 Asia-Pacific Subcutaneous Biologics Market Size by Region

8.3.1 Asia-Pacific Subcutaneous Biologics Revenue by Region (2016-2026)

8.3.2 China Subcutaneous Biologics Market Size and Forecast (2016-2026)

8.3.3 Japan Subcutaneous Biologics Market Size and Forecast (2016-2026)

8.3.4 South Korea Subcutaneous Biologics Market Size and Forecast (2016-2026)

8.3.5 India Subcutaneous Biologics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Subcutaneous Biologics Market Size and Forecast (2016-2026)

8.3.7 Australia Subcutaneous Biologics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Subcutaneous Biologics Revenue by Type (2016-2026)

9.2 South America Subcutaneous Biologics Revenue by Application (2016-2026)

9.3 South America Subcutaneous Biologics Market Size by Country

9.3.1 South America Subcutaneous Biologics Revenue by Country (2016-2026)

9.3.2 Brazil Subcutaneous Biologics Market Size and Forecast (2016-2026)

9.3.3 Argentina Subcutaneous Biologics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Subcutaneous Biologics Revenue by Type (2016-2026)

10.2 Middle East & Africa Subcutaneous Biologics Revenue by Application (2016-2026)

10.3 Middle East & Africa Subcutaneous Biologics Market Size by Country

10.3.1 Middle East & Africa Subcutaneous Biologics Revenue by Country (2016-2026)

10.3.2 Turkey Subcutaneous Biologics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Subcutaneous Biologics Market Size and Forecast (2016-2026)

10.3.4 UAE Subcutaneous Biologics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Subcutaneous Biologics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Subcutaneous Biologics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Subcutaneous Biologics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Subcutaneous Biologics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Subcutaneous Biologics Revenue Market Share by Region (2021-2026)

Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors

Table 7. Abbott Laboratories Major Business

Table 8. Abbott Laboratories Subcutaneous Biologics Product and Solutions

Table 9. Abbott Laboratories Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Pfizer Inc. Corporate Information, Head Office, and Major Competitors

Table 11. Pfizer Inc. Major Business

Table 12. Pfizer Inc. Subcutaneous Biologics Product and Solutions

Table 13. Pfizer Inc. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Genentech Inc. Corporate Information, Head Office, and Major Competitors

Table 15. Genentech Inc. Major Business

Table 16. Genentech Inc. Subcutaneous Biologics Product and Solutions

Table 17. Genentech Inc. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Novartis AG Corporate Information, Head Office, and Major Competitors

Table 19. Novartis AG Major Business

Table 20. Novartis AG Subcutaneous Biologics Product and Solutions

Table 21. Novartis AG Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Biogen Idec Corporate Information, Head Office, and Major Competitors

Table 23. Biogen Idec Major Business

Table 24. Biogen Idec Subcutaneous Biologics Product and Solutions

Table 25. Biogen Idec Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. AbbVie Inc. Corporate Information, Head Office, and Major Competitors

Table 27. AbbVie Inc. Major Business

Table 28. AbbVie Inc. Subcutaneous Biologics Product and Solutions

Table 29. AbbVie Inc. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. F. Hoffmann-La Roche AG Corporate Information, Head Office, and Major Competitors

Table 31. F. Hoffmann-La Roche AG Major Business

Table 32. F. Hoffmann-La Roche AG Subcutaneous Biologics Product and Solutions

Table 33. F. Hoffmann-La Roche AG Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Bristol-Myers Squibb Corporate Information, Head Office, and Major Competitors

Table 35. Bristol-Myers Squibb Major Business

Table 36. Bristol-Myers Squibb Subcutaneous Biologics Product and Solutions

Table 37. Bristol-Myers Squibb Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Eisai Inc. Corporate Information, Head Office, and Major Competitors

Table 39. Eisai Inc. Major Business

Table 40. Eisai Inc. Subcutaneous Biologics Product and Solutions

Table 41. Eisai Inc. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Takeda Pharmaceuticals Ltd. Corporate Information, Head Office, and Major Competitors

Table 43. Takeda Pharmaceuticals Ltd. Major Business

Table 44. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product and Solutions

Table 45. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors

Table 47. Alnylam Pharmaceuticals Major Business

Table 48. Alnylam Pharmaceuticals Subcutaneous Biologics Product and Solutions

Table 49. Alnylam Pharmaceuticals Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Bayer AG Corporate Information, Head Office, and Major Competitors

Table 51. Bayer AG Major Business

Table 52. Bayer AG Subcutaneous Biologics Product and Solutions

Table 53. Bayer AG Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors

Table 55. GlaxoSmithKline Major Business

Table 56. GlaxoSmithKline Subcutaneous Biologics Product and Solutions

Table 57. GlaxoSmithKline Subcutaneous Biologics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Global Subcutaneous Biologics Revenue (USD Million) by Players (2019-2021)

Table 59. Global Subcutaneous Biologics Revenue Share by Players (2019-2021)

Table 60. Breakdown of Subcutaneous Biologics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 61. Subcutaneous Biologics Players Head Office, Products and Services Provided

Table 62. Subcutaneous Biologics Mergers & Acquisitions in the Past Five Years

Table 63. Subcutaneous Biologics New Entrants and Expansion Plans

Table 64. Global Subcutaneous Biologics Revenue (USD Million) by Type (2016-2021)

Table 65. Global Subcutaneous Biologics Revenue Share by Type (2016-2021)

Table 66. Global Subcutaneous Biologics Revenue Forecast by Type (2021-2026)

Table 67. Global Subcutaneous Biologics Revenue by Application (2016-2021)

Table 68. Global Subcutaneous Biologics Revenue Forecast by Application (2021-2026)

Table 69. North America Subcutaneous Biologics Revenue by Type (2016-2021) & (USD Million)

Table 70. North America Subcutaneous Biologics Revenue by Type (2021-2026) & (USD Million)

Table 71. North America Subcutaneous Biologics Revenue by Application (2016-2021) & (USD Million)

Table 72. North America Subcutaneous Biologics Revenue by Application (2021-2026) & (USD Million)

Table 73. North America Subcutaneous Biologics Revenue by Country (2016-2021) & (USD Million)

Table 74. North America Subcutaneous Biologics Revenue by Country (2021-2026) & (USD Million)

Table 75. Europe Subcutaneous Biologics Revenue by Type (2016-2021) & (USD Million)

Table 76. Europe Subcutaneous Biologics Revenue by Type (2021-2026) & (USD Million)

Table 77. Europe Subcutaneous Biologics Revenue by Application (2016-2021) & (USD Million)

Table 78. Europe Subcutaneous Biologics Revenue by Application (2021-2026) & (USD Million)

Table 79. Europe Subcutaneous Biologics Revenue by Country (2016-2021) & (USD Million)

Table 80. Europe Subcutaneous Biologics Revenue by Country (2021-2026) & (USD Million)

Table 81. Asia-Pacific Subcutaneous Biologics Revenue by Type (2016-2021) & (USD Million)

Table 82. Asia-Pacific Subcutaneous Biologics Revenue by Type (2021-2026) & (USD Million)

Table 83. Asia-Pacific Subcutaneous Biologics Revenue by Application (2016-2021) & (USD Million)

Table 84. Asia-Pacific Subcutaneous Biologics Revenue by Application (2021-2026) & (USD Million)

Table 85. Asia-Pacific Subcutaneous Biologics Revenue by Region (2016-2021) & (USD Million)

Table 86. Asia-Pacific Subcutaneous Biologics Revenue by Region (2021-2026) & (USD Million)

Table 87. South America Subcutaneous Biologics Revenue by Type (2016-2021) & (USD Million)

Table 88. South America Subcutaneous Biologics Revenue by Type (2021-2026) & (USD Million)

Table 89. South America Subcutaneous Biologics Revenue by Application (2016-2021) & (USD Million)

Table 90. South America Subcutaneous Biologics Revenue by Application (2021-2026) & (USD Million)

Table 91. South America Subcutaneous Biologics Revenue by Country (2016-2021) & (USD Million)

Table 92. South America Subcutaneous Biologics Revenue by Country (2021-2026) & (USD Million)

Table 93. Middle East & Africa Subcutaneous Biologics Revenue by Type (2016-2021) & (USD Million)

Table 94. Middle East & Africa Subcutaneous Biologics Revenue by Type (2021-2026) & (USD Million)

Table 95. Middle East & Africa Subcutaneous Biologics Revenue by Application (2016-2021) & (USD Million)

Table 96. Middle East & Africa Subcutaneous Biologics Revenue by Application (2021-2026) & (USD Million)

Table 97. Middle East & Africa Subcutaneous Biologics Revenue by Country (2016-2021) & (USD Million)

Table 98. Middle East & Africa Subcutaneous Biologics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Subcutaneous Biologics Picture

Figure 2. Global Subcutaneous Biologics Revenue Market Share by Delivery System in 2020

Figure 3. Syringe

Figure 4. Wearable injector

Figure 5. Automatic injector

Figure 6. Implants

Figure 7. Subcutaneous Biologics Revenue Market Share by Distribution Channel in 2020

Figure 8. Hospital pharmacies Picture

Figure 9. Retail pharmacies Picture

Figure 10. Drug stores Picture

Figure 11. Online pharmacies Picture

Figure 12. Global Subcutaneous Biologics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Subcutaneous Biologics Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Subcutaneous Biologics Revenue Market Share by Region (2016-2026)

Figure 15. Global Subcutaneous Biologics Revenue Market Share by Region in 2020

Figure 16. North America Subcutaneous Biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Subcutaneous Biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Subcutaneous Biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Subcutaneous Biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Subcutaneous Biologics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Subcutaneous Biologics Market Drivers

Figure 22. Subcutaneous Biologics Market Restraints

Figure 23. Subcutaneous Biologics Market Trends

Figure 24. Abbott Laboratories Recent Developments and Future Plans

Figure 25. Pfizer Inc. Recent Developments and Future Plans

Figure 26. Genentech Inc. Recent Developments and Future Plans

Figure 27. Novartis AG Recent Developments and Future Plans

Figure 28. Biogen Idec Recent Developments and Future Plans

Figure 29. AbbVie Inc. Recent Developments and Future Plans

Figure 30. F. Hoffmann-La Roche AG Recent Developments and Future Plans

Figure 31. Bristol-Myers Squibb Recent Developments and Future Plans

Figure 32. Eisai Inc. Recent Developments and Future Plans

Figure 33. Takeda Pharmaceuticals Ltd. Recent Developments and Future Plans

Figure 34. Alnylam Pharmaceuticals Recent Developments and Future Plans

Figure 35. Bayer AG Recent Developments and Future Plans

Figure 36. GlaxoSmithKline Recent Developments and Future Plans

Figure 37. Global Subcutaneous Biologics Revenue Share by Players in 2020

Figure 38. Subcutaneous Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 39. Global Top 3 Players Subcutaneous Biologics Revenue Market Share in 2020

Figure 40. Global Top 10 Players Subcutaneous Biologics Revenue Market Share in 2020

Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 42. Global Subcutaneous Biologics Revenue Share by Type in 2020

Figure 43. Global Subcutaneous Biologics Market Share Forecast by Type (2021-2026)

Figure 44. Global Subcutaneous Biologics Revenue Share by Application in 2020

Figure 45. Global Subcutaneous Biologics Market Share Forecast by Application (2021-2026)

Figure 46. North America Subcutaneous Biologics Sales Market Share by Type (2016-2026)

Figure 47. North America Subcutaneous Biologics Sales Market Share by Application (2016-2026)

Figure 48. North America Subcutaneous Biologics Revenue Market Share by Country (2016-2026)

Figure 49. United States Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Canada Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Mexico Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Europe Subcutaneous Biologics Sales Market Share by Type (2016-2026)

Figure 53. Europe Subcutaneous Biologics Sales Market Share by Application (2016-2026)

Figure 54. Europe Subcutaneous Biologics Revenue Market Share by Country (2016-2026)

Figure 55. Germany Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. France Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. United Kingdom Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Russia Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Italy Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Asia-Pacific Subcutaneous Biologics Sales Market Share by Type (2016-2026)

Figure 61. Asia-Pacific Subcutaneous Biologics Sales Market Share by Application (2016-2026)

Figure 62. Asia-Pacific Subcutaneous Biologics Revenue Market Share by Region (2016-2026)

Figure 63. China Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Japan Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. South Korea Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. India Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Southeast Asia Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Australia Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. South America Subcutaneous Biologics Sales Market Share by Type (2016-2026)

Figure 70. South America Subcutaneous Biologics Sales Market Share by Application (2016-2026)

Figure 71. South America Subcutaneous Biologics Revenue Market Share by Country (2016-2026)

Figure 72. Brazil Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Argentina Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Middle East and Africa Subcutaneous Biologics Sales Market Share by Type (2016-2026)

Figure 75. Middle East and Africa Subcutaneous Biologics Sales Market Share by Application (2016-2026)

Figure 76. Middle East and Africa Subcutaneous Biologics Revenue Market Share by Country (2016-2026)

Figure 77. Turkey Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Saudi Arabia Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. UAE Subcutaneous Biologics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Methodology

Figure 81. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

+1

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketquest.biz